logo
    Comparative Infection Related Outcomes Between Recipients of an Axial Continuous-flow and an Intrapericardial Centrifugal Continuous-flow Left Ventricular Assist Device: A Single Center Experience
    0
    Citation
    0
    Reference
    10
    Related Paper
    This report details two cases of left ventricular assist device (LVAD)-related fungal infection. In both cases, the infection occurred within the device and formed an obstruction resulting in intermittent variation in the output of the LVAD. This was manifested by a change in the pattern of aortic insufficiency (AI) from continuous to intermittent on transesophageal echocardiography. Recognition of this finding may allow for noninvasive diagnosis of LVAD flow obstruction.
    Objectives: Mechanical circulatory support with the HeartMate I LVAD was used as a bridge to HTX in patients developing cardiac failure while on the waiting list for heart transplantation. We report on our experience in the treatment of this high risk group in comparison to heart transplantation without assist device.
    Bridge to transplantation
    Single Center
    Bridge (graph theory)
    Destination therapy
    Artificial heart
    Citations (0)
    The objective of this study is to review and analyze readmission data for patients who received a continuous flow left ventricular assist device (LVAD).A retrospective review of 88 patients implanted with a continuous-flow LVAD between June 2006 and June 2014 was performed. Reason for readmission, frequency, length of stay, and procedures performed during each readmission were recorded. All patients were followed in our LVAD clinic and all readmissions were reported to our program.Sixty-seven patients (76%) were discharged following their hospitalization for LVAD implant. In these patients, indication for LVAD support consisted of bridge to transplant (78%) and destination therapy (22%). Total device support time was 30,482 days, with an average support time of 455 ± 376 days. Forty-two patients (63%) were readmitted at least once, with an average length of readmission stay of nine days (median = 6). There were 129 readmissions totaling 1264 hospital days. The main reason for readmission was infection (17%). Despite this relatively high readmission rate, patients spent 86% of their time outside the hospital.Although common, LVAD readmissions can be appropriately managed with patients spending the majority of their support time at home. doi: 10.1111/jocs.12744 (J Card Surg 2016;31:361-364).
    Destination therapy
    Hospital Readmission
    Citations (18)
    Objective: Continuous-flow left ventricular assist devices (CF-LVAD) are now allowing for years of safe circulatory support with enhanced quality of life. Our aim was to identify positive predicators for a successful longtime VAD therapy.
    Destination therapy
    Citations (0)
    Background: Based on the REMATCH (Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure) study experience, readmissions after LVAD implantation are thought to be frequent. The purpose of this study was to determine the occurrence and causes of readmissions after implantation of axial flow left ventricular assist device (LVAD).
    Citations (0)